<DOC>
	<DOC>NCT00219609</DOC>
	<brief_summary>To determine whether UK-390,957 is a safe treatment for premature ejaculation.</brief_summary>
	<brief_title>Assessment Of Safety Of UK-390,957</brief_title>
	<detailed_description />
	<criteria>Subjects will have completed one of the phase 2 trials (A3871022/ A3871027/ A3871029) and will have met the diagnostic criteria for premature ejaculation as defined by DSMIV No drug related serious adverse events</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>